Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.

Saved in:

Bibliographic Details
Title:	Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Authors:	Rahaghi, Franck F.¹ rahaghf@ccf.org, Balasubramanian, Vijay P.², Bourge, Robert C.³, Burger, Charles D.⁴, Chakinala, Murali M.⁵, Eggert, Michael S.⁶, Elwing, Jean M.⁷, Feldman, Jeremy⁸, King, Christopher⁹, Klinger, James R.¹⁰, Mathai, Stephen C.¹¹, McConnell, John Wesley¹², Palevsky, Harold I.¹³, Restrepo‐Jaramillo, Ricardo¹⁴, Safdar, Zeenat¹⁵, Sager, Jeffrey S.¹⁶, Sood, Namita¹⁷, Sulica, Roxana¹⁸, James White, R.¹⁹, Hill, Nicholas S.²⁰
Source:	Pulmonary Circulation. Apr2022, Vol. 12 Issue 2, p1-13. 13p.
Database:	Academic Search Ultimate

Description
ISSN:	20458932
DOI:	10.1002/pul2.12055